
Andrew Salner
Medical Director, Hartford HealthCare Cancer Institute · University of Connecticut School of Medicine
Credentials: · ·
History
- Present
Hartford HealthCare Cancer Institute Center · University of Connecticut School of Medicine
1981–1986- 1977–1981
Harvard School of Medicine
- 1976–1977
1972–1976
Research
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
New England Journal of Medicine · 2016 · 1,060 citations
American Cancer Society prostate cancer survivorship care guidelines
Current Anthropology · 2014 · 363 citations
Effect of computer support on younger women with breast cancer
Journal of General Internal Medicine · 2001 · Last of 11 authors · 271 citations

6 papers

6 papers

4 papers
- SB
4 papers
- AK
3 papers

3 papers

3 papers
- JP
3 papers
Clinical trials
- 2025–2034
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
- 2025–2033
Site PI · Recruiting · Phase 2, Phase 3
Novartis Pharmaceuticals
- 2023–2033
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Site PI · Recruiting · Phase 4
Novartis Pharmaceuticals

